Literature DB >> 20881249

Role of transient receptor potential channels in cholecystokinin-induced activation of cultured vagal afferent neurons.

Huan Zhao1, Steven M Simasko.   

Abstract

Cholecystokinin (CCK), an endogenous brain-gut peptide, is released after food intake and promotes the process of satiation via activation of the vagus nerve. In vitro, CCK increases cytosolic calcium concentrations and produces membrane depolarization in a subpopulation of vagal afferent neurons. However, the specific mechanisms and ionic conductances that mediate these effects remain unclear. In this study we used calcium imaging, electrophysiological measurements, and single cell PCR analysis on cultured vagal afferent neurons to address this issue directly. A cocktail of blockers of voltage-dependent calcium channels (VDCC) failed to block CCK-induced calcium responses. In addition, SKF96365, a compound that blocks both VDCC and the C family of transient receptor potential (TRP) channels, also failed to prevent responses to CCK. Together these results suggest that CCK-induced calcium influx is not subsequent to the membrane depolarization. Ruthenium red, an inhibitor of the TRPV family and TRPA1, blocked both depolarizing responses to CCK and CCK-induced calcium increases, but had no effect on the KCl-induced calcium response. Selective block of TRPV1 and TRPA1 channels with SB366791 and HC030031, respectively, had minor effects on the CCK-induced response. Application of 2-aminoethoxydiphenyl borate, an activator of select TRPV channels but a blocker of several TRPC channels, either had no effect or enhanced the responses to CCK. Further, results from PCR experiments revealed a significant clustering of TRPV2-5 in neurons expressing CCK1 receptors. These observations demonstrate that CCK-induced increases in cytosolic calcium and membrane depolarization of vagal afferent neurons are likely mediated by TRPV channels, excluding TRPV1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20881249      PMCID: PMC2954709          DOI: 10.1210/en.2010-0504

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  56 in total

1.  Thermosensitive transient receptor potential channels in vagal afferent neurons of the mouse.

Authors:  Lei Zhang; Sarahlouise Jones; Kate Brody; Marcello Costa; Simon J H Brookes
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-01-15       Impact factor: 4.052

2.  Cholecystokinin decreases food intake in rats.

Authors:  J Gibbs; R C Young; G P Smith
Journal:  J Comp Physiol Psychol       Date:  1973-09

3.  Effect of cholecystokinin receptor antagonist on pancreatic responses to exogenous gastrin and cholecystokinin and to meal stimuli.

Authors:  S J Konturek; J Tasler; M Cieszkowski; K Szewczyk; M Hladij
Journal:  Gastroenterology       Date:  1988-04       Impact factor: 22.682

4.  Inhibition of gastric emptying is a physiological action of cholecystokinin.

Authors:  H T Debas; O Farooq; M I Grossman
Journal:  Gastroenterology       Date:  1975-05       Impact factor: 22.682

5.  Characterization and function of TWIK-related acid sensing K+ channels in a rat nociceptive cell.

Authors:  B Y Cooper; R D Johnson; K K Rau
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

6.  Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats.

Authors:  G P Smith; C Jerome; R Norgren
Journal:  Am J Physiol       Date:  1985-11

7.  Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist.

Authors:  M J Gunthorpe; H K Rami; J C Jerman; D Smart; C H Gill; E M Soffin; S Luis Hannan; S C Lappin; J Egerton; G D Smith; A Worby; L Howett; D Owen; S Nasir; C H Davies; M Thompson; P A Wyman; A D Randall; J B Davis
Journal:  Neuropharmacology       Date:  2004-01       Impact factor: 5.250

8.  Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat.

Authors:  G P Smith; C Jerome; B J Cushin; R Eterno; K J Simansky
Journal:  Science       Date:  1981-08-28       Impact factor: 47.728

9.  Capsaicin application to central or peripheral vagal fibers attenuates CCK satiety.

Authors:  E H South; R C Ritter
Journal:  Peptides       Date:  1988 May-Jun       Impact factor: 3.750

10.  L-364,718, a new CCK antagonist, inhibits postprandial pancreatic secretion and PP release in dogs.

Authors:  R Hosotani; P Chowdhury; P L Rayford
Journal:  Dig Dis Sci       Date:  1989-03       Impact factor: 3.199

View more
  15 in total

Review 1.  Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system.

Authors:  Peter Holzer
Journal:  Pharmacol Ther       Date:  2011-03-21       Impact factor: 12.310

2.  Mercaptoacetate and fatty acids exert direct and antagonistic effects on nodose neurons via GPR40 fatty acid receptors.

Authors:  Rebecca A Darling; Huan Zhao; Dallas Kinch; Ai-Jun Li; Steven M Simasko; Sue Ritter
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-04-23       Impact factor: 3.619

3.  Contributing mechanisms underlying desensitization of cholecystokinin-induced activation of primary nodose ganglia neurons.

Authors:  Cody W Kowalski; Jonathan E M Lindberg; Daniel K Fowler; Steven M Simasko; James H Peters
Journal:  Am J Physiol Cell Physiol       Date:  2020-02-19       Impact factor: 4.249

4.  TRPC6 in simulated microgravity of intervertebral disc cells.

Authors:  Alfredo Franco-Obregón; Elena Cambria; Helen Greutert; Timon Wernas; Wolfgang Hitzl; Marcel Egli; Miho Sekiguchi; Norbert Boos; Oliver Hausmann; Stephen J Ferguson; Hiroshi Kobayashi; Karin Wuertz-Kozak
Journal:  Eur Spine J       Date:  2018-07-02       Impact factor: 3.134

5.  Gastric vagal afferent neuropathy following experimental spinal cord injury.

Authors:  Emily M Besecker; Emily N Blanke; Gina M Deiter; Gregory M Holmes
Journal:  Exp Neurol       Date:  2019-11-05       Impact factor: 5.330

6.  TMEM16B determines cholecystokinin sensitivity of intestinal vagal afferents of nodose neurons.

Authors:  Runping Wang; Yongjun Lu; Michael Z Cicha; Madhu V Singh; Christopher J Benson; Christopher J Madden; Mark W Chapleau; François M Abboud
Journal:  JCI Insight       Date:  2019-03-07

7.  Pharmacological investigations of the cellular transduction pathways used by cholecystokinin to activate nodose neurons.

Authors:  Huan Zhao; Dallas C Kinch; Steven M Simasko
Journal:  Auton Neurosci       Date:  2011-06-12       Impact factor: 3.145

8.  Leptin-induced spine formation requires TrpC channels and the CaM kinase cascade in the hippocampus.

Authors:  Matasha Dhar; Gary A Wayman; Mingyan Zhu; Talley J Lambert; Monika A Davare; Suzanne M Appleyard
Journal:  J Neurosci       Date:  2014-07-23       Impact factor: 6.167

9.  Mercaptoacetate blocks fatty acid-induced GLP-1 secretion in male rats by directly antagonizing GPR40 fatty acid receptors.

Authors:  Ai-Jun Li; Qing Wang; Thu T Dinh; Steve M Simasko; Sue Ritter
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-01-20       Impact factor: 3.619

10.  Genetic and pharmacological evidence for low-abundance TRPV3 expression in primary vagal afferent neurons.

Authors:  Shaw-Wen Wu; Jonathan E M Lindberg; James H Peters
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-02-03       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.